About Us
Stroke
Our product
Partners & Investors
News & Media
Contact

About Us

Nothing to display, yet.

About Us

Company Overview
Management Team
Project Team
Board of directors

February 5, 2018

ACTICOR BIOTECH COMPLETED ITS PHASE I CLINICAL TRIAL WITH ACT017 ACHIEVING ITS SAFETY AND TOLERABILITY PRIMARY ENDPOINTS

Paris, February 5th, 2018 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including stroke and other thrombosis disorders like pulmonary embolism, announced today the completion of its phase I clinical trial in healthy volunteers with its drug candidate, ACT017. ACT017 is a humanized monoclonal antibody fragment (Fab) […]

Main navigation

About Us
Stroke
Our product
Press Releases
Media Coverage
Publications
Investors

Contact

Contact Us
Follow us on Twitter
Follow us on LinkedIn

Acticor Biotech
Bâtiment Inserm U1148
Hôpital Bichat, Secteur Claude Bernard
46 rue Henri Huchard
75877 Paris Cedex 18